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Genome-wide association studies (GWASs) are critically dependent on detailed knowledge of the pattern of linkage disequilibrium (LD)
in the human genome. GWASs generate lists of variants, usually SNPs, ranked according to the significance of their association to a trait.
Downstream analyses generally focus on the gene or genes that are physically closest to these SNPs and ignore their LD profile with other
SNPs. We have developed a flexible R package (LDsnpR) that efficiently assigns SNPs to genes on the basis of both their physical position
and their pairwise LD with other SNPs. We used the positional-binning and LD-based-binning approaches to investigate whether
including these ‘‘LD-based’’ SNPs would affect the interpretation of three published GWASs on bipolar affective disorder (BP) and of
the imputed versions of two of these GWASs. We show how including LD can be important for interpreting and comparing GWASs.
In the published, unimputed GWASs, LD-based binning effectively ‘‘recovered’’ 6.1%–8.3% of Ensembl-defined genes. It altered the
ranks of the genes and resulted in nonnegligible differences between the lists of the top 2,000 genes emerging from the two binning
approaches. It also improved the overall gene-based concordance between independent BP studies. In the imputed datasets, although
the increases in coverage (>0.4%) and rank changes were more modest, even greater concordance between the studies was observed,
attesting to the potential of LD-based binning on imputed data as well. Thus, ignoring LD can result in the misinterpretation of the
GWAS findings and have an impact on subsequent genetic and functional studies.Over the past decade, genome-wide association studies
(GWASs) have revolutionized the analysis of human
complex genetic traits. By scanning hundreds of thou-
sands of genetic variants, typically SNPs, in hundreds or
thousands of individuals, they search for the variant(s)
that associate with a particular disease or trait. Critical to
the development and evolution of GWASs has been the
creation of the International HapMap Project,1 which
has cataloged the common patterns of human genetic vari-
ation, including the linkage disequilibrium (LD) between
SNPs. Knowledge of this LD, or nonrandom association
of alleles at multiple loci, has made it possible to identify
informative subsets of SNPs (i.e., ‘‘tagging SNPs’’) that
capture the bulk of genome-wide variation and has re-
sulted in affordable genome-wide genotyping. To date,
almost 1,000 GWASs have been published and have tested
hundreds of human traits and reported thousands of
significant associations (Catalog of Published Genome-
Wide Association Studies2). Previously known associations
have been confirmed, and new candidates have been
implicated.3 However, a general sense of disappointment
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The Amexpectation that they would unravel the genetic basis of
complex traits.4,5 Recent analyses reveal that a large
proportion of the ‘‘missing heritability’’5,6 can be ex-
plained by a polygenic model that considers all GWAS
SNPs simultaneously,7–9 but these studies provide no clues
about the identity of the susceptibility variants or the
underlying biology of the trait.6 Thus, much attention
has been given to uncovering and characterizing this
‘‘missing’’ or ‘‘hidden’’ heritability.6,10
In a conventional GWAS, each SNP is considered sepa-
rately (the ‘‘single-marker’’ approach), resulting in a list
of variants ranked according to the statistical significance
of their association to the trait (i.e., their p value).11 The
‘‘top hits’’ are typically reported, and the relevance of
each finding, as well as the focus of future work, is
primarily based on the functional unit(s), namely gene(s),
implicated by the associated SNP. Furthermore, gene-based
methods are increasingly being applied as complementary
approaches to the analysis of GWAS data. These methods
take the gene instead of the individual SNP as the basic
unit of association and thus allow aggregation of SNPs of
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Table 1. Study Descriptions and Summary of Coverage for Positional-Binning and LD-Based-Binning Approaches for Original, Unimputed
Datasets
WTCCCa TOPb Germanc
Sample size
(cases/controls)
1,868/2,938 198/336 682/1,300
Platform used Affymetrix 500K Affymetrix6.0 Illumina HumanHap550v3
Number of post-QC
SNPs for binning
468,648 615,396 511,978
Binning data Positional
binning
LD-based
binning
Differenced Positional
binning
LD-based
binning
Differenced Positional
binning
LD-based
binning
Differenced
Number of genes
coverede
30,610
(83.4%)
33,443
(91.1%)
2,833
(9.3%)
31,823
(86.7%)
33,905
(92.4%)
2,082
(6.5%)
31,708
(86.4%)
33,861
(92.3%)
2,153
(6.8%)
Number of post-QC
SNPs binned
237,869
(50.8%)
277,534
(59.2%)
39,665
(16.7%)
307,949
(50.0%)
363,570
(59.1%)
55,621
(18.1%)
272,914
(53.3%)
308,634
(60.2%)
35,720
(13.1%)
Number of SNPs
binned to only 1 gene
199,752
(84.0%)
178,544
(64.3%)
21,208
(10.6%)
259,223
(84.2%)
234,036
(64.4%)
25,187
(9.7%)
228,098
(83.6%)
209,458
(67.9%)
18,640
(8.2%)
Number of SNPs
binned to ten or more
135
(0.057%)
2,537
(0.91%)
2,402 174
(0.057%)
3,106
(0.85%)
2,932 141
(0.052%)
2,072
(0.67%)
1,931
Mean number of SNPs
per bin (median)
9.4 (4) 15.2 (10) 6.6 (4) 11.7 (5) 19.4 (13) 8.4 (6) 10.5 (5) 15.4 (10) 5.6 (4)
Range (min–max) 1–514 1–515 0–87 1–687 1–701 0–112 1–655 1–665 0–64
Number of genes
with only one SNP
4,830
(15.8%)
1,531
(4.6%)
3,299
(68.3%)
3,604
(11.3%)
992
(2.9%)
2,612
(72.5%)
3,647
(11.5%)
595
(1.8%)
3,052
(83.7%)
The following abbreviation is used: QC, quality control.
aThe UK-based Wellcome Trust Case Control Consortium (WTCCC) BP GWAS.17
bThe Norwegian Thematically Organized Psychosis (TOP) BP GWAS.18
cA German BP GWAS.19
dPercentages indicate percent increase or decrease from positional to LD-based binning.
eEnsembl 54 (May 2009) genes (total N ¼ 36,693) tagged by at least one SNP.the multiple-testing burden.12–14 They enable the incorpo-
ration of biological knowledge for greater insight into the
mechanisms underlying the trait and are essential for
subsequent pathway-based approaches.13 Gene-based
methods also facilitate direct comparison of independent
studies because they are unaffected by allelic heterogeneity
and potential differences in SNP coverage and LD
patterns.15
The success of both single-marker and gene-based
approaches is critically dependent on the correct assign-
ment of SNPs to genes. At the single-marker level, the
aim is to identify the gene(s) that the associated SNP is
tagging. At the gene level, the aim is to attribute all SNPs
tagging a particular gene to that gene. Although LD can
span hundreds of kilobases,16,17 when GWAS results
emerge, the SNPs of interest are typically assigned to the
nearest gene or transcript within a specified distance.14
In turn, genes are typically represented only by the SNPs
that are physically located within the transcribed region
or predefined flanking region.13 It is not systematically
taken into consideration that an associated SNP might be
in high LD with another SNP (genotyped or not) located
hundreds of kilobases away in a different gene or that
a genotyped SNP positioned outside the defined bound-
aries of a gene is tagging that gene. Here, we show that
ignoring LD discards valuable information and potentially728 The American Journal of Human Genetics 90, 727–733, April 6, 2leads to the incorrect localization of the association signal
and might mislead the interpretation of GWAS data.
We have therefore developed a flexible R package
(LDsnpR) that systematically assigns SNPs to genes (or rele-
vant predefined genome ‘‘bins’’) by using SNP association
results (e.g., p values), bin definitions, and precalculated
pairwise LD data (e.g., r2 values) provided by the user
(Figure S1, available online). By default, LDsnpR assigns
a SNP to a bin if that SNP is located within the physical
boundaries of that bin (i.e., the ‘‘positional-binning’’
approach). Then, as a unique feature of this package, the
user has the option of also assigning a genotyped SNP to
a bin if that SNP is in high pairwise LD with another SNP
(genotyped or not) located within the physical boundaries
of that bin (i.e., ‘‘LD-based-binning’’ approach). Although
a genotyped SNP cannot be assigned to a particular gene
more than once, it can be assigned to more than one gene.
As proof of principal, we used LDsnpR to assess the
impact of the LD-based-binning approach (versus the posi-
tional-binning approach) on the results of three published
GWASs on bipolar disorder (BP), each unimputed and gen-
otyped on a different platform. The three GWASs are (1)
the UK-based Wellcome Trust Case Control Consortium
(WTCCC) BP GWAS,18 (2) the Norwegian Thematically
Organized Psychosis (TOP) BP GWAS,19 and (3) a German
BP GWAS20 (Table 1). Each GWAS had been previously012
Table 2. Study Descriptions and Summary of Coverage for Positional-Binning and LD-Based-Binning Approaches for Imputed Datasets
TOPa Imputedb Germanc Imputedb
Sample size (cases/controls) 198/336 657/1,308
Imputation reference
panel
HapMap Phase III (CEU) 1,000 Genomes (pilot 1, CEU) and HapMap Phase III (CEU)
Post-QC SNPs for binning 992,161 4,825,148
Binning data Positional
binning
LD-based
binning
Differenced Positional
binning
LD-based
binning
Differenced
Number of genes coverede 33,242 (90.6%) 34,193 (93.2%) 951 (2.9%) 32,116 (87.5%) 32,259 (87.9%) 143 (0.4%)
Number of post-QC SNPs
binned
521,720 (52.6%) 612,316 (61.7%) 90,596 (17.4%) 2,394,441 (49.6%) 2,613,493 (54.2%) 219,052 (9.1%)
Number of SNPs binned
to only one gene
431,808 (43.5%) 367,671 (37.1%) 64,137 (14.9%) 1,979,660 (41.0%) 1,855,413 (38.5%) 124,247 (6.3%)
Number of SNPs binned
to ten or more
267 (0.03%) 7,967 (0.8%) 7,700 1,272 (0.03%) 16,807 (0.3%) 15,535
Mean number of SNPs per
bin (median)
19.3 (9) 35.9 (25) 17.1 (12) 91.6 (44) 130.6 (84) 39.5 (26)
Range (min–max) 1–1,046 1–1,062 0–214 1–5,570 1–5,573 0–573
Number of genes with
only one SNP
1,795 (5.4%) 651 (1.9%) 1,144 (63.7%) 241 (0.8%) 208 (0.6%) 33 (13.7%)
The following abbreviation is used: QC, quality control.
aThe Norwegian Thematically Organized Psychosis (TOP) BP GWAS.18
bImputation details: the Norwegian TOP dataset was imputed according to the ENIGMA protocol with the use of MACH imputation software38 and HapMap Phase
III (CEU) as the reference panel. The German dataset was imputed with IMPUTE2 software39 and the 1,000 Genomes Project (Pilot 1, CEU) and HapMap Phase III
(CEU) as reference panels.
cA German BP GWAS.19
dPercentages indicate percent increase or decrease from positional to LD-based binning.
eEnsembl 54 (May 2009) genes (total N ¼ 36,693) tagged by at least one SNP.approved by the relevant local research ethics committees,
and all participants had provided written informed
consent.18–20 In addition, we assessed the impact of LD-
based binning on imputed versions of the TOP and
German GWASs, in which ungenotyped markers had
been statistically inferred11 on the basis of LD from
different reference panels (i.e., HapMap Phase III for TOP;
HapMap Phase III and 1,000 Genomes21 for German)
(Table 2).
BP is a severe complex psychiatric disorder that shows
high heritability (60%–80%) but for which clear genetic
risk factors remain elusive.4 Although several GWASs on
BP have been performed (Catalog of Published Genome-
Wide Association Studies2), the findings have shown little
overlap at both the SNP and gene levels. Also, only a hand-
ful of SNPs have achieved genome-wide significance
(<~108), and these SNPs only explain less than 3% of
the heritability,4,22 suggesting that psychiatric disorders,
such as BP, might be less amenable to GWASs than other
disorders.5,23 However, systematic LD-based gene binning
has not been applied to these datasets, possibly contrib-
uting to the apparent lack of success. Thus, we assessed
the effects of the LD-based-binning approach relative to
the traditional positional-binning approach with respect
to (1) gene coverage, (2) changes in the results and, poten-
tially, the interpretation of findings, and (3) pairwise
concordance of the findings among the BP GWASs.The AmIn brief, for LDsnpR, gene bin definitions were based on
the Human Ensembl release 54 (May 2009) gene identifiers
with unambiguous positional information (N ¼ 36,693).
We extended these gene bins by another 10 kb on either
side to best capture potential regulatory regions.24,25 The
LD data were based on HapMap Phase II release 27 and
were restricted to that of the CEU (Utah residents with
ancestry from northern and western Europe from the
CEPH collection) sample. We set the pairwise LD at the
widely accepted threshold of r2 R 0.826 to limit the loss
of power needed for the detection of association at the
linked locus.27
We first compared the extent of coverage between the
positional-binning and LD-based-binning approaches in
the published, unimputed datasets (Table 1). By allowing
us to identify the intergenic SNPs that tag genes, LD-based
binning resulted in a ~13%–18% increase in the number of
SNPs included in the gene-binning process. Intergenic
SNPs represent ~40% of GWAS trait-associated SNPs.3
Notably, LD-based binning ‘‘recovered’’ >2,000 genes
(>6%) in all three datasets, increasing the proportion of
Ensembl 54 genes tagged by at least one SNP from ~83%
to>91%. Furthermore, there was an increase in the density
of coverage; an average of 5.6 to 8.4 (median of four to six)
SNPs were added per gene, and there was an overall
decrease (>68%) in the number of genes tagged by only
one SNP.erican Journal of Human Genetics 90, 727–733, April 6, 2012 729
Table 3. Effect of LD-Based Binning on Ranks of Genes within Each
GWAS
WTCCC TOP German
TOP
Imputed
German
Imputed
Correlationa of
gene ranks
0.79 0.83 0.83 0.83 0.92
Number of genes
moving into top 2,000
with LD-based binning
681
(34.0%)
601
(30.0%)
538
(26.9%)
558
(27.9%)
309
(15.5%)
aSpearman rank correlation (i.e., rho).The imputed datasets also yielded increased coverage
(Table 2) but, as expected, to a lesser extent depending
on the reference panel used for imputation. Although
HapMap II (i.e., LDsnpR reference panel) is denser than
HapMap III28 (i.e., reference panel for the TOP and
German studies), imputation on the 1,000 Genomes data
(i.e., reference panel for the German study) potentially
gives the densest coverage. For the TOP and German
imputed datasets, LD-based binning resulted in an increase
of 17.4% and 9.1%, respectively, in the number of SNPs
included in the gene-binning process and the recovery of
951 (2.9%) and 143 (0.4%) genes, respectively. Although
this is only a small proportion of the total gene coverage,
the recovery of these genes enables them to be considered
as candidates for BP association and might lead to a better
understanding of the biology should the true association
stem from them. Also of note, in the German GWAS, LD-
based binning alone achieved an overall gene coverage of
92.3% (imputation achieved 87.5% coverage, and imputa-
tion combined with LD-based binning achieved 87.9%
coverage), suggesting that under some scenarios, LD-based
binning alone can offer the most coverage. As with the
original GWASs, there was an increase in the density of
coverage; an average of 17.1 and 39.5 (median 12 and
26) SNPs were added per gene for the TOP and German
imputed datasets, respectively. There was also a decrease
in the number of genes tagged by only one SNP (63.7%);
the decrease was not as notable for the German imputed
dataset (13.7%).
We next assessed the effects of the LD-based-binning
approach on the results of the three GWASs at both the
single-marker and gene levels. At the single-marker level,
we used the positional-binning and LD-based-binning
approaches to compare the genes tagged by the most
significant SNPs reported in the original publications18–20
(Table S1). Although LD-based binningmade no difference
to the results of the TOP BP study, three of the 14 SNPs in
the WTCCC BP study and three of the eight SNPs in the
German BP study implicated additional or alternative
genes. Interpreting GWAS single-marker results demands
fastidious consideration because when given only the
p value, it is not immediately clear where the true source
of the association originates17 and thus which is the true
candidate gene. The overall potential for mislocalizing the
association signal was underscored by the reduced number730 The American Journal of Human Genetics 90, 727–733, April 6, 2of SNPs tagging only one gene and the increased number of
SNPs tagging ten or more genes after LD-based binning
(Tables 1 and 2). Further investigations, such as expression
studies,20 are therefore warranted before attributing puta-
tive causality to a gene and, as a result, nominating it as
the focus of future fine-mapping, functional, and other
expensive and time-consuming follow-up studies.29
As previously stated, gene-based analyses are ideal for
pathway approaches, which aid in the interpretation of
GWAS results by exploiting prior biological annotation to
determine whether certain biological functions are en-
riched (i.e., overrepresented) among the more significant
genes in a dataset. These methods require one measure of
association (or score) for each gene on the basis of the indi-
vidual SNP association signals. Here, we used a function in
LDsnpR to score each gene with the most significant
p value (i.e., the minimum p value approach), which was
adjusted for the number of SNPs tagging that gene by
a modification of Sidak’s correction.30 The minimum
p value approach is the most widely used gene-scoring
approach31 and assumes an underlying genetic architec-
ture in which a single SNP, or locus, within the gene
contributes to the disorder. The modification performs at
least as well as a powerful regression-based method in cor-
recting for the bias due to SNP number.32 In this study, the
correlation between the gene score and the number
of SNPs in the bin was reduced from Pearson r2 > 0.30 to
r2 < 0.020 in all three datasets after the modified Sidak
correction was applied. Also, permutation-based gene-set
analysis, as implemented in PLINK,33 on the German
GWAS confirmed the high correlation between modified
Sidak-corrected p values and permutation-based p values
(r2 > 0.95). The genes were scored for both the posi-
tional-binning and LD-based-binning approaches and
were compared.
The overall correlation in the ranks of the genes between
the two approaches was <0.83 in the three original data-
sets and the TOP imputed dataset, indicating that LD-
based binning altered the scores and the subsequent ranks
of the genes. Although not as large, changes in rank were
also observed in the German imputed dataset (Table 3).
When a resampling analysis was performed on the unim-
puted WTCCC dataset (it randomly excluded 5% of the
samples [20 repetitions]), the average overall correlation
in ranks due to LD-based binning (0.80) was lower than
that resulting from random fluctuations in the datasets
(>0.87), indicating greater changes due to LD (Table S2).
Such changes in rank are likely to impact threshold-free,
rank-based pathway approaches, such as gene-set-enrich-
ment analysis,34 which aims to determine whether a prede-
fined set of genes is enriched at the top of a ranked list. By
inspecting the top 2,000 genes emerging from the two
binning approaches, we found a 27%–34% difference
between the two gene lists in the three unimputed and
the TOP imputed datasets and a 15.5% difference in the
German imputed dataset. Here, the resampling analysis
in the WTCCC GWAS found that random fluctuations in012
Table 4. Pairwise Concordance between GWASs at SNP and Gene Levels
WTCCC vs. TOP WTCCC vs. German TOP vs. German
TOP Imputed vs.
German Imputed
SNP level 0.0066 (0.00018) 0.0037 (0.31) 0.0018 (0.51) 0.00023 (0.83)
Gene level (positional binning) 0.030 (1.78 3 107) 0.0017 (0.78) 0.023 (4.78 3 105) 0.068 (<2.2 3 1016)
Gene level (LD-based binning) 0.077 (<2.2 3 1016) 0.027 (7.24 3 107) 0.053 (<2.2 3 1016) 0.098 (<2.2 3 1016)
The Spearman rank correlation and p value (in parentheses) are shown for each pairwise comparison.the dataset led to a 25.6% change in the top 2,000 genes,
whereas LD-based binning resulted in a 30.7% difference
(Table S2). For threshold-based approaches, such as Inge-
nuity Pathway Analysis and ALIGATOR,35 in which a list
of genes meeting a specified threshold is tested for overrep-
resentation of a particular biological function, LD-based
binning could result in the submission of a substantially
different list. Changes in the ranks of the genes are thus
likely to impact the outcome of these analyses and possibly
the overall biological interpretation of the findings. The
extent to which these LD-based changes are meaningful
will also depend on the study design and resulting power,
given that the resampling analysis shows that substantial
changes in results can also occur as a result of slight
changes in the dataset.
Finally, we assessed whether LD-based binning
improved the concordance of results across studies, espe-
cially in light of the aforementioned changes in the ranks
of the genes. We compared the positional-binning and LD-
based-binning approaches by performing pairwise rank-
correlation analyses of the three GWAS datasets at both
the SNP level and the gene level (Table 4). When the posi-
tional-binning approach was used, little to no correlation
was observed at both the SNP and gene levels. However,
with LD-based binning, the overall rank correlation
increased by ~3% and was more significant for all pairwise
comparisons, including the imputed datasets. Interest-
ingly, the greatest concordance was observed when LD-
based binning was combined with imputation, high-
lighting the complementary nature of the two methods.
Although there was no obvious increase in overlap in the
top gene hits (data not shown), this increase in overall
concordance warrants the use of the LD-based-binning
approach for the reanalysis of these and other datasets in
the search for common functional gene sets and pathways.
The observed increase in correlation persisted even when
regions of high LD, such as the MHC (major histocompat-
ibility complex) region on chromosome 6, were excluded
(data not shown).
Our study illustrates the importance of systematically
accounting for LD in the interpretation of GWAS results.
To the best of our knowledge, our study is the first to quan-
tify the added value of LD-based binning; in particular, it
shows an increase in the concordance of results across
independent GWASs of a trait as complex as BP. Excluding
LD defies the basic premise of the GWAS approach by dis-
carding valuable genetic information and risking theThe Amincorrect localization of the association signal and the
misinterpretation of the biology of the findings. Our find-
ings call for a reanalysis of previously published GWAS
data via the LD-based-binning approach and for future
GWASs to adopt this method automatically. LDsnpR facil-
itates this process by efficiently assigning SNPs to genes
and provides the option of scoring the genes for direct
entry into pathway-analysis tools. LDsnpR’s flexible frame-
work allows the application of different gene-scoring
methods; the application of such methods is necessary
for detecting gene-based associations under different
genetic architectures for the traits.31 The user-definable r2
parameter enables the scanning of a greater range of allele
frequencies at the linked locus.27 Bin definitions and pre-
calculated pairwise LD information can be updated on
the basis of the user’s interests and the information avail-
able. LD-based binning might also serve as a complemen-
tary and/or alternative approach to imputation. In partic-
ular, as high-quality LD data from the 1,000 Genomes
Project21 emerges, all GWASs, including those previously
subjected to imputation, might benefit from simple and
efficient LD-based binning at no extra cost. As we show
here, LD-based binning can further enhance imputed
GWASs, albeit to a lesser extent than unimputed datasets.
More tools that allow for incorporation of LD into the
interpretation of GWAS data are emerging,36,37 further
testifying to the importance of this approach. Also, for
studies genotyped on different platforms and/or imputed
with the use of different reference panels, LD-based
binning enables uniform comparison at both the gene
and pathway levels.
It is crucial to note that our study, as well as LDsnpR,
only addresses SNP-to-gene assignment. Issues involving
the derivation of the most accurate gene score (which
accounts for gene size and LD between SNPs), the handling
of SNPs that are assigned tomultiple, possibly overlapping,
genes, and the correlation between genes are unresolved
obstacles for pathway-analysis approaches13 and are
beyond the scope of this paper. Furthermore, the benefits
of LD-based binning will be unique to each GWAS depend-
ing on the trait and its true underlying genetic architec-
ture, the study design, and the extent of SNP coverage.Supplemental Data
Supplemental Data include one figure and two tables and can be
found with this article online at http://www.cell.com/AJHG.erican Journal of Human Genetics 90, 727–733, April 6, 2012 731
Acknowledgments
We acknowledge Isabel Hanson Scientific Writing for critical help
with the manuscript preparation. This work was supported by
grants from the Bergen Research Foundation, the University of
Bergen, the Research Council of Norway (FUGE, Psyksik Helse,
and eVita), UNI Computing, Western Norway Regional Health
Authority (Helse Vest), the Dr. Einar Martens Fund, South-Eastern
Norway Regional Health Authority (Helse Sør-Øst), the National
Institutes of Health and the National Heart, Lung, and Blood Insti-
tute (U01 HL089856, RO1 MH087590 and R01 MH081862), and
the German Federal Ministry of Education and Research (National
Genome Research Network 2, the National Genome Research
Network plus, and the Integrated Genome Research Network
MooDS [grant 01GS08144 to S.C.]). LDsnpR was developed within
the eSysbio project. We acknowledge Ha˚kon Sagehaug for contrib-
uting Java code and members of the BioStar QA community for
their help and interesting discussions.
Received: September 6, 2011
Revised: February 16, 2012
Accepted: February 27, 2012
Published online: March 22, 2012
Web Resources
The URLs for data presented herein are as follows:
1,000 Genomes Project, http://www.1000genomes.org/
Catalog of Published Genome-Wide Association Studies, www.
genome.gov/gwastudies/
ENIGMAprotocol, http://enigma.loni.ucla.edu/protocols/genetics-
protocols/
HapMap Project, http://hapmap.ncbi.nlm.nih.gov/
Human Ensembl Release 54, http://may2009.archive.ensembl.
org/biomart/martview/11839bb5ec82fb10bf0333540fa09c46
IMPUTE2 Software, http://mathgen.stats.ox.ac.uk/impute/
impute_v2.html
Ingenuity Pathway Analysis, http://www.ingenuity.com/
LDsnpR, http://services.cbu.uib.no/software/ldsnpr
PLINK, http://pngu.mgh.harvard.edu/~purcell/plink/
R Archive Network, http://cran.r-project.org
References
1. International HapMap Consortium. (2005). A haplotype map
of the human genome. Nature 437, 1299–1320.
2. Hindorff, L.A., Sethupathy, P., Junkins, H.A., Ramos, E.M.,
Mehta, J.P., Collins, F.S., and Manolio, T.A. (2009). Potential
etiologic and functional implications of genome-wide associa-
tion loci for human diseases and traits. Proc. Natl. Acad. Sci.
USA 106, 9362–9367.
3. Manolio, T.A. (2010). Genomewide association studies and
assessment of the risk of disease. N. Engl. J. Med. 363, 166–176.
4. Bondy, B. (2011). Genetics in psychiatry: Are the promises
met? World J. Biol. Psychiatry 12, 81–88.
5. Gershon, E.S., Alliey-Rodriguez, N., and Liu, C. (2011). After
GWAS: Searching for genetic risk for schizophrenia and
bipolar disorder. Am. J. Psychiatry 168, 253–256.
6. Stranger, B.E., Stahl, E.A., and Raj, T. (2011). Progress and
promise of genome-wide association studies for human
complex trait genetics. Genetics 187, 367–383.
7. Gibson, G. (2010). Hints of hidden heritability in GWAS. Nat.
Genet. 42, 558–560.732 The American Journal of Human Genetics 90, 727–733, April 6, 28. Davies, G., Tenesa, A., Payton, A., Yang, J., Harris, S.E., Lie-
wald, D., Ke, X., Le Hellard, S., Christoforou, A., Luciano,
M., et al. (2011). Genome-wide association studies establish
that human intelligence is highly heritable and polygenic.
Mol. Psychiatry 16, 996–1005.
9. Lee, S.H., Wray, N.R., Goddard, M.E., and Visscher, P.M.
(2011). Estimating missing heritability for disease from
genome-wide association studies. Am. J. Hum. Genet. 88,
294–305.
10. Cantor, R.M., Lange, K., and Sinsheimer, J.S. (2010). Priori-
tizing GWAS results: A review of statistical methods and
recommendations for their application. Am. J. Hum. Genet.
86, 6–22.
11. McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Goldstein, D.B.,
Little, J., Ioannidis, J.P., and Hirschhorn, J.N. (2008). Genome-
wide association studies for complex traits: Consensus, uncer-
tainty and challenges. Nat. Rev. Genet. 9, 356–369.
12. Bergen, S.E., Balhara, Y.P., Christoforou, A., Cole, J., Degen-
hardt, F., Dempster, E., Fatjo´-Vilas, M., Khedr, Y., Lopez,
L.M., Lysenko, L., et al. (2011). Summaries from the XVIII
World Congress of Psychiatric Genetics, Athens, Greece, 3-7
October 2010. Psychiatr. Genet. 21, 136–172.
13. Wang, K., Li, M., and Hakonarson, H. (2010). Analysing bio-
logical pathways in genome-wide association studies. Nat.
Rev. Genet. 11, 843–854.
14. Wang, K., Li, M., and Bucan, M. (2007). Pathway-based
approaches for analysis of genomewide association studies.
Am. J. Hum. Genet. 81, 1278–1283.
15. Neale, B.M., and Sham, P.C. (2004). The future of association
studies: Gene-based analysis and replication. Am. J. Hum.
Genet. 75, 353–362.
16. Hinds, D.A., Stuve, L.L., Nilsen, G.B., Halperin, E., Eskin, E.,
Ballinger, D.G., Frazer, K.A., and Cox, D.R. (2005). Whole-
genome patterns of common DNA variation in three human
populations. Science 307, 1072–1079.
17. Lawrence, R., Evans, D.M., Morris, A.P., Ke, X., Hunt, S., Pao-
lucci, M., Ragoussis, J., Deloukas, P., Bentley, D., and Cardon,
L.R. (2005). Genetically indistinguishable SNPs and their
influence on inferring the location of disease-associated vari-
ants. Genome Res. 15, 1503–1510.
18. Wellcome Trust Case Control Consortium. (2007). Genome-
wide association study of 14,000 cases of seven common
diseases and 3,000 shared controls. Nature 447, 661–678.
19. Djurovic, S., Gustafsson, O., Mattingsdal, M., Athanasiu, L.,
Bjella, T., Tesli, M., Agartz, I., Lorentzen, S., Melle, I., Morken,
G., and Andreassen, O.A. (2010). A genome-wide association
study of bipolar disorder in Norwegian individuals, followed
by replication in Icelandic sample. J. Affect. Disord. 126,
312–316.
20. Cichon, S., Mu¨hleisen, T.W., Degenhardt, F.A., Mattheisen,
M., Miro´, X., Strohmaier, J., Steffens, M., Meesters, C., Herms,
S., Weingarten, M., et al; Bipolar Disorder Genome Study
(BiGS) Consortium. (2011). Genome-wide association study
identifies genetic variation in neurocan as a susceptibility
factor for bipolar disorder. Am. J. Hum. Genet. 88, 372–381.
21. 1000 Genomes Consortium. (2010). A map of human genome
variation from population-scale sequencing. Nature 467,
1061–1073.
22. So, H.C., Gui, A.H., Cherny, S.S., and Sham, P.C. (2011). Eval-
uating the heritability explained by known susceptibility vari-
ants: A survey of ten complex diseases. Genet. Epidemiol. 35,
310–317.012
23. Neale, B.M., and Purcell, S. (2008). The positives, protocols,
and perils of genome-wide association. Am. J. Med. Genet.
B. Neuropsychiatr. Genet. 147B, 1288–1294.
24. Blow, M.J., McCulley, D.J., Li, Z., Zhang, T., Akiyama, J.A.,
Holt, A., Plajzer-Frick, I., Shoukry, M., Wright, C., Chen, F.,
et al. (2010). ChIP-Seq identification of weakly conserved
heart enhancers. Nat. Genet. 42, 806–810.
25. Vandiedonck, C., Taylor, M.S., Lockstone, H.E., Plant, K., Tay-
lor, J.M., Durrant, C., Broxholme, J., Fairfax, B.P., and Knight,
J.C. (2011). Pervasive haplotypic variation in the spliceo-tran-
scriptome of the human major histocompatibility complex.
Genome Res. 21, 1042–1054.
26. Spencer, C.C., Su, Z., Donnelly, P., and Marchini, J. (2009).
Designing genome-wide association studies: Sample size,
power, imputation, and the choice of genotyping chip. PLoS
Genet. 5, e1000477.
27. Wray, N.R. (2005). Allele frequencies and the r2 measure of
linkage disequilibrium: Impact on design and interpretation
of association studies. Twin Res. Hum. Genet. 8, 87–94.
28. Santos, P.S., Ho¨hne, J., Poerner, F., da Grac¸a Bicalho, M.,
Uchanska-Ziegler, B., and Ziegler, A. (2011). Does the new
HapMap throw the baby out with the bath water? Eur. J.
Hum. Genet. 19, 733–734.
29. Ioannidis, J.P., Thomas, G., and Daly, M.J. (2009). Validating,
augmenting and refining genome-wide association signals.
Nat. Rev. Genet. 10, 318–329.
30. Saccone, S.F., Hinrichs, A.L., Saccone, N.L., Chase, G.A., Kon-
vicka, K., Madden, P.A., Breslau, N., Johnson, E.O., Hatsukami,
D., Pomerleau, O., et al. (2007). Cholinergic nicotinic receptor
genes implicated in a nicotine dependence association study
targeting 348 candidate genes with 3713 SNPs. Hum. Mol.
Genet. 16, 36–49.
31. Lehne, B., Lewis, C.M., and Schlitt, T. (2011). From SNPs to
genes: disease association at the gene level. PLoS ONE 6,
e20133.
32. Segre`, A.V., Groop, L., Mootha, V.K., Daly, M.J., and Altshuler,
D.; DIAGRAM Consortium; MAGIC investigators. (2010).The AmCommon inherited variation in mitochondrial genes is not
enriched for associations with type 2 diabetes or related glyce-
mic traits. PLoS Genet. 6, e1001058.
33. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira,
M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly,
M.J., and Sham, P.C. (2007). PLINK: A tool set for whole-
genome association and population-based linkage analyses.
Am. J. Hum. Genet. 81, 559–575.
34. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S.,
Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub,
T.R., Lander, E.S., and Mesirov, J.P. (2005). Gene set enrich-
ment analysis: A knowledge-based approach for interpreting
genome-wide expression profiles. Proc. Natl. Acad. Sci. USA
102, 15545–15550.
35. Holmans, P., Green, E.K., Pahwa, J.S., Ferreira, M.A., Purcell,
S.M., Sklar, P., Owen, M.J., O’Donovan, M.C., and Craddock,
N.; Wellcome Trust Case-Control Consortium. (2009). Gene
ontology analysis of GWA study data sets provides insights
into the biology of bipolar disorder. Am. J. Hum. Genet. 85,
13–24.
36. Hong, M.G., Pawitan, Y., Magnusson, P.K., and Prince, J.A.
(2009). Strategies and issues in the detection of pathway
enrichment in genome-wide association studies. Hum. Genet.
126, 289–301.
37. Zhang, K., Chang, S., Cui, S., Guo, L., Zhang, L., and Wang, J.
(2011). ICSNPathway: Identify candidate causal SNPs and
pathways from genome-wide association study by one analyt-
ical framework. Nucleic Acids Res. 39 (Web Server issue),
W437–443.
38. Li, Y., Willer, C.J., Ding, J., Scheet, P., and Abecasis, G.R.
(2010). MaCH: Using sequence and genotype data to estimate
haplotypes and unobserved genotypes. Genet. Epidemiol. 34,
816–834.
39. Howie, B.N., Donnelly, P., andMarchini, J.A. (2009). A flexible
and accurate genotype imputationmethod for the next gener-
ation of genome-wide association studies. PLoS Genet. 5,
e1000529.erican Journal of Human Genetics 90, 727–733, April 6, 2012 733
